Lumason .19 mg/mg (Sulfur Hexafluoride INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION) .19 mg/mg

Lumason .19 mg/mg is a diagnostic imaging agent used to enhance ultrasound images. This lyophilized powder for suspension is administered intravenously or intravesically for improved visualization.

Strength

.19 mg/mg

Pack Size

20 VIAL in 1 BOX (0270-7097-08) / 25 mg in 1 VIAL

Manufacturer / TM Owner

BRACCO DIAGNOSTICS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lumason .19 mg/mg is primarily used as a contrast agent in ultrasound imaging. It helps to enhance the visibility of blood flow and tissue structures, aiding in the diagnosis of various conditions. This agent is often utilized in procedures where detailed imaging is required, such as evaluating heart function or detecting abnormalities in blood vessels.

Side Effects

When administered, Lumason .19 mg/mg typically enhances the clarity of ultrasound images, allowing healthcare professionals to better assess internal structures. The effects are temporary and designed to provide clear, detailed images during the diagnostic procedure.

Precautions & Warnings

Lumason .19 mg/mg should be handled with care, following standard protocols for intravenous and intravesical administration. It is important to ensure that the product is stored and prepared correctly to maintain its efficacy and safety. Always follow the guidelines provided by healthcare professionals.

Avoid Interactions

Lumason .19 mg/mg may interact with certain medications or conditions. It is advisable to inform healthcare providers about any existing medical conditions or medications being taken before administration. Specific interactions should be discussed with a healthcare professional.

Frequently Asked Questions

Lumason .19 mg/mg is used as a contrast agent to enhance ultrasound images, aiding in the diagnosis of various conditions by improving the visibility of blood flow and tissue structures.

Lumason .19 mg/mg is administered either intravenously or intravesically, depending on the specific diagnostic procedure.

The primary effect of Lumason .19 mg/mg is to enhance the clarity of ultrasound images, providing detailed visualization of internal structures during diagnostic procedures.

Yes, Lumason .19 mg/mg should be handled and administered according to standard protocols. It is important to follow healthcare professional guidelines for storage, preparation, and administration.

Potential interactions with other medications or conditions should be discussed with a healthcare professional before administration.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.